000 01670 a2200445 4500
005 20250511182911.0
264 0 _c19921030
008 199210s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1992.10.10.1635
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLum, B L
245 0 0 _aAlteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cOct 1992
300 _a1635-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCyclosporine
_xadministration & dosage
650 0 4 _aDrug Interactions
650 0 4 _aDrug Resistance
650 0 4 _aEtoposide
_xpharmacokinetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
700 1 _aKaubisch, S
700 1 _aYahanda, A M
700 1 _aAdler, K M
700 1 _aJew, L
700 1 _aEhsan, M N
700 1 _aBrophy, N A
700 1 _aHalsey, J
700 1 _aGosland, M P
700 1 _aSikic, B I
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 10
_gno. 10
_gp. 1635-42
856 4 0 _uhttps://doi.org/10.1200/JCO.1992.10.10.1635
_zAvailable from publisher's website
999 _c1409533
_d1409533